Deepa Prasad

We are a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC™ gene targeted chimera small molecules. The company’s GeneTAC™ molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address the underlying cause of disease. Design’s lead program is focused on the treatment of Friedreich ataxia, followed by programs in Fuchs endothelial corneal dystrophy and myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions. For more information, please visit designtx.com.

For life sciences companies pursuing digital transformation, we offer the leading technology to rapidly develop, launch, and scale digital solutions. Our cloud-based platform is the trusted foundation for companion apps, algorithms, connected combination products, healthcare provider interfaces and other Software as a Medical Device (SaMD).   Our customers partner with BrightInsight to differentiate their therapies and harness unique real-world data to drive measurable value. With a track record of successful product launches that yield business and clinical ROI for top life sciences companies’ flagship brands in their largest markets, BrightInsight is the proven leader in this space.

The pioneer in deploying machine learning into clinical workflows, Curai Health is an AI-powered virtual clinic delivering primary care to more people at a fraction of the cost. Easy-to-use and convenient, Curai Health partners with insurers and health systems to keep patients engaged in their care over time, improving health outcomes and reducing costs. Curai Health has been combining the expertise of clinicians with the efficiencies of artificial intelligence since its founding in 2017. We’re building a diverse, world-class team across multiple disciplines. If you’re interested, we’re always looking for the best kind of people.

Ginger is now part of Headspace. Ginger is reinventing mental healthcare by coupling data science and virtual delivery to provide immediate, personal support for anyone. Care from our on-demand mental health system is delivered through the Ginger app, available on iOS and Android, where members can conveniently connect with Ginger’s team of behavioral health coaches - 24/7, 365 days a year. For those in need of additional support, a therapist or psychiatrist can be added to their care team. Over half a million people have access to Ginger through leading employers, health plans, and other partners. The World Economic Forum has identified Ginger’s AI technology as a Technology Pioneer, and the company was recognized as one of the top 10 Most Innovative Companies in Healthcare by Fast Company.

Lumen Bioscience develops oral antibody therapeutics.

Viome | A Viome Life Sciences, Inc. Company. We provide the industry’s only direct-to-consumer healthcare test that analyzes microbial and human gene expressions (mRNA), with technology exclusively licensed from Los Alamos National Lab, in order to provide individuals with health insights and the nutrition they need. By joining Viome, you are joining a revolutionary movement. A movement that – for the first time in human history – will make becoming ill a matter of choice, and not simply bad luck. Scientists have worked for over a decade to develop this technology that offers unprecedented visibility into your body. With this, we can create a unique profile of the biochemistry and ecosystem inside of you, and make personalized, actionable, and adaptive recommendations for your health. Our at-home tests are not just one-time tests, but your true health companion, enabling you to monitor your health over time. Your results and recommendations adapt to your changing ecosystem so you are always aware and taking action towards maximizing your vitality and lifespan. The Viome team is made up of scientists, engineers, researchers and entrepreneurs who are passionate about radically improving the wellness of our customers.

We are a clinical-stage biotechnology company developing a new class of therapies based on its platform of GeneTAC™ gene targeted chimera small molecules. The company’s GeneTAC™ molecules are designed to either dial up or dial down the expression of a specific disease-causing gene to address the underlying cause of disease. Design’s lead program is focused on the treatment of Friedreich ataxia, followed by programs in Fuchs endothelial corneal dystrophy and myotonic dystrophy type-1 and discovery efforts for multiple other serious degenerative disorders caused by nucleotide repeat expansions. For more information, please visit designtx.com.

For life sciences companies pursuing digital transformation, we offer the leading technology to rapidly develop, launch, and scale digital solutions. Our cloud-based platform is the trusted foundation for companion apps, algorithms, connected combination products, healthcare provider interfaces and other Software as a Medical Device (SaMD).   Our customers partner with BrightInsight to differentiate their therapies and harness unique real-world data to drive measurable value. With a track record of successful product launches that yield business and clinical ROI for top life sciences companies’ flagship brands in their largest markets, BrightInsight is the proven leader in this space.

The pioneer in deploying machine learning into clinical workflows, Curai Health is an AI-powered virtual clinic delivering primary care to more people at a fraction of the cost. Easy-to-use and convenient, Curai Health partners with insurers and health systems to keep patients engaged in their care over time, improving health outcomes and reducing costs. Curai Health has been combining the expertise of clinicians with the efficiencies of artificial intelligence since its founding in 2017. We’re building a diverse, world-class team across multiple disciplines. If you’re interested, we’re always looking for the best kind of people.

Ginger is now part of Headspace. Ginger is reinventing mental healthcare by coupling data science and virtual delivery to provide immediate, personal support for anyone. Care from our on-demand mental health system is delivered through the Ginger app, available on iOS and Android, where members can conveniently connect with Ginger’s team of behavioral health coaches - 24/7, 365 days a year. For those in need of additional support, a therapist or psychiatrist can be added to their care team. Over half a million people have access to Ginger through leading employers, health plans, and other partners. The World Economic Forum has identified Ginger’s AI technology as a Technology Pioneer, and the company was recognized as one of the top 10 Most Innovative Companies in Healthcare by Fast Company.

Lumen Bioscience develops oral antibody therapeutics.